Gordana Apic

Meatable is leading the charge in revolutionizing how the meat industry sources and produces meat. We are a partner to the industry and provide the science and technology to sustainably produce affordable, great-tasting, real meat at scale. Meatable’s cultivated meat technology is designed to complement and integrate into the existing traditional meat industry’s supply chains, offering opportunities for partnerships that strengthen the entire system. We accomplish this without harming animals or the planet, 25x times faster than traditional protein. Meatable is positioned to be THE solution for feeding a hungry planet in the future.

The world of Radiology is changing: high-tech hardware, improving image quality and ever-increasing amounts of images are the new normal. Our human abilities become the limiting factor and its on us to keep up with technology. At mediaire, we support you in seeing what matters: our AI-powered tools for MRI diagnostics are your personal upgrade. Get the most out of your images and come to a more accurate diagnosis at an even faster speed. To us, seeing what matters means understanding what matters to you. Thats why we dont just improve our current products, but are continuously expanding our portfolio to provide you with maximum coverage, everyday

bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey. For more information on bit.bio’s trademarks, visit www.bit.bio/trademarks

A company delivering delivers services solutions to the research community in the biotechnology industry. With a strong expertise in systems toxicology, the company develops tools for scientists who need to better understand on- and- off target mechanisms of action of compounds and the links between genes, targets, chemicals and pathologies. Our flagship products are toxicology ontologies, databases and analytical software . Our databases comprise decades of expert curation of scientific literature and capture information about a range of toxic endpoints, chemical structure information (covering all known drugs and tool compounds) with protein and gene targets, toxicology relevant signalling pathways etc. We develop predictive software, as well as software for analyzing -omics data. Our focus is dealing with information and methods in order to elucidate modes of action and toxicity and help explain the underlying biological pathways.

Der VdU vertritt seit 1954 als Wirtschaftsverband branchenübergreifend die Interessen von Unternehmerinnen. Seit über 65 Jahren setzt sich der VdU für mehr weibliches Unternehmertum, mehr Frauen in Führungspositionen und bessere Bedingungen für Frauen in der Wirtschaft ein. Derzeit repräsentiert der VdU über 1.800 frauengeführte, insbesondere mittelständische Unternehmen aus Industrie, Handwerk, Handel und Dienstleistung. Die Mitglieder des VdU erwirtschaften zusammen einen Jahresumsatz von 85 Milliarden Euro und beschäftigen 500.000 Menschen.

Meatable is leading the charge in revolutionizing how the meat industry sources and produces meat. We are a partner to the industry and provide the science and technology to sustainably produce affordable, great-tasting, real meat at scale. Meatable’s cultivated meat technology is designed to complement and integrate into the existing traditional meat industry’s supply chains, offering opportunities for partnerships that strengthen the entire system. We accomplish this without harming animals or the planet, 25x times faster than traditional protein. Meatable is positioned to be THE solution for feeding a hungry planet in the future.

The world of Radiology is changing: high-tech hardware, improving image quality and ever-increasing amounts of images are the new normal. Our human abilities become the limiting factor and its on us to keep up with technology. At mediaire, we support you in seeing what matters: our AI-powered tools for MRI diagnostics are your personal upgrade. Get the most out of your images and come to a more accurate diagnosis at an even faster speed. To us, seeing what matters means understanding what matters to you. Thats why we dont just improve our current products, but are continuously expanding our portfolio to provide you with maximum coverage, everyday

bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey. For more information on bit.bio’s trademarks, visit www.bit.bio/trademarks

A company delivering delivers services solutions to the research community in the biotechnology industry. With a strong expertise in systems toxicology, the company develops tools for scientists who need to better understand on- and- off target mechanisms of action of compounds and the links between genes, targets, chemicals and pathologies. Our flagship products are toxicology ontologies, databases and analytical software . Our databases comprise decades of expert curation of scientific literature and capture information about a range of toxic endpoints, chemical structure information (covering all known drugs and tool compounds) with protein and gene targets, toxicology relevant signalling pathways etc. We develop predictive software, as well as software for analyzing -omics data. Our focus is dealing with information and methods in order to elucidate modes of action and toxicity and help explain the underlying biological pathways.